DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 195 filers reported holding DYNE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.30 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $57,703,949 | +24.3% | 1,635,136 | 0.0% | 5.33% | +46.1% |
Q1 2024 | $46,421,511 | +237.2% | 1,635,136 | +58.0% | 3.65% | +223.7% |
Q4 2023 | $13,767,309 | +48.4% | 1,035,136 | 0.0% | 1.13% | +10.9% |
Q3 2023 | $9,274,819 | +42.7% | 1,035,136 | +79.2% | 1.02% | +126.3% |
Q2 2023 | $6,498,473 | -2.3% | 577,642 | 0.0% | 0.45% | -2.8% |
Q1 2023 | $6,654,436 | +99294.1% | 577,642 | 0.0% | 0.46% | -40.1% |
Q4 2022 | $6,695 | -99.9% | 577,642 | 0.0% | 0.77% | -4.8% |
Q3 2022 | $7,336,000 | +84.9% | 577,642 | 0.0% | 0.81% | +103.5% |
Q2 2022 | $3,968,000 | -28.7% | 577,642 | 0.0% | 0.40% | +3.9% |
Q1 2022 | $5,568,000 | -18.9% | 577,642 | 0.0% | 0.38% | -7.5% |
Q4 2021 | $6,868,000 | -26.8% | 577,642 | 0.0% | 0.41% | -1.7% |
Q3 2021 | $9,381,000 | -22.8% | 577,642 | 0.0% | 0.42% | -20.0% |
Q2 2021 | $12,154,000 | +35.5% | 577,642 | 0.0% | 0.53% | +67.0% |
Q1 2021 | $8,971,000 | +35.6% | 577,642 | +83.4% | 0.32% | +6.8% |
Q4 2020 | $6,615,000 | +4.0% | 315,000 | 0.0% | 0.30% | -19.8% |
Q3 2020 | $6,360,000 | – | 315,000 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,220,034 | $25,574,792 | 34.99% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,039,011 | 23.77% |
Atlas Venture Life Science Advisors, LLC | 9,885,449 | $113,880,372 | 15.42% |
TCG Crossover Management, LLC | 1,650,150 | $19,009,728 | 3.70% |
Logos Global Management LP | 1,700,000 | $19,584,000 | 2.80% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 433,751 | $4,988,137 | 1.39% |
Octagon Capital Advisors LP | 692,945 | $7,982,726 | 1.15% |
Deep Track Capital, LP | 2,334,633 | $26,894,972 | 1.10% |
Altium Capital Management LP | 155,000 | $1,785,600 | 0.99% |
HighVista Strategies LLC | 102,431 | $1,180,005 | 0.96% |